Hosted as part of Innovation Week 2016, this event will explore the different options for commercialising discoveries in medical research. Commercialisation of university-based research is increasing in Australia and contention exists over whether forming a start-up company, or licensing to a more resourceful company, provides better outcomes for the inventor, the university and the economy. Our panel, with experience in venture capital, angel investing, start-up companies, industry and universities, will debate the merits and pitfalls encountered with each approach.
As well as learn about the various funding options for commercialising research, the audience will hear about growing trends in the local and global biotechnology sector, new investment funds soon to be launched and how innovation and research power a robust economy.
The debate will be moderated by the highly engaging Michelle Gallaher and also feature time for networking over a drink and audience questions.
Chris Nave, Brandon Capital Partners (Medical Research Commercialisation Fund)
Elaine Stead, Blue Sky Ventures
Elane Zelcer, Accelerating Commercialisation
Julian Clark, The Walter and Eliza Hall Institute
Anna Lavelle, AusBiotech
Daniel Grant, La Trobe University (ex-Pfizer)
Michelle Gallaher, The Social Science
5.30 Networking drinks
6.00 Welcome and introductions
6.10 Moderated panel discussion
7.00 Audience questions
Innovation Week brings together people from science, technology and business to support putting good science and research to use. Supported by the Australian Science and Innovation Forum (ASIF) and Australian Academy of Technological Sciences and Engineering, Innovation Week 2016 will take place in Melbourne, Sydney and Perth from November 7-11. ASIF aims to tackle gaps in the innovation pipeline by connecting all parts of the scientific and technological entrepreneurship spectrum. Members come from academia, government bodies and industry. For more information, go to: https://innovationweek2016.org